Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients

NCT00265226 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1020

Enrollment

OTHER_GOV

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: Intra-dermal administration of Mycobacterium w

Sponsor

Ministry of Science and Technology, India